Severe Hypoglycemia in the U.S.: What New Diabetes Guidelines Mean for Patients and Families

The bottom line: Severe hypoglycemia — dangerously low blood sugar that requires help from another person — is still sending Americans to emergency rooms every year. But updated national diabetes guidelines and expanded Medicare coverage for glucose monitoring are changing how doctors and families work to prevent it.

In December 2025, the American Diabetes Association (ADA) released its Standards of Care in Diabetes—2026, the primary clinical guideline used across the United States. The update reinforces a clear message: preventing severe hypoglycemia should be a priority for nearly everyone treated with insulin or certain diabetes medications.

Why Severe Hypoglycemia Still Matters in 2026

According to the CDC’s National Diabetes Statistics Report, more than 40 million people in the United States are living with diabetes. Many use insulin or other glucose-lowering medications, which can sometimes cause blood sugar to drop too low.

Severe hypoglycemia is defined as a low blood sugar episode that causes mental or physical impairment and requires assistance from another person. Someone may become confused, pass out, have a seizure, or be unable to swallow safely.

It is dangerous because it can lead to:

Falls and fractures, especially in older adults
Seizures or loss of consciousness
Heart rhythm disturbances
Emergency department visits and hospitalizations

A major peer-reviewed review in JAMA has found that severe hypoglycemia is associated with higher risks of cardiovascular events and death. The relationship is complex — low blood sugar may both reflect underlying illness and contribute to stress on the heart — but the association is strong enough that prevention is a central safety goal.

Who Is at Highest Risk?

The ADA identifies several groups at higher risk of severe low blood sugar:

Older adults
People with long-standing diabetes
Those with kidney disease
People with prior severe hypoglycemia
Individuals with “hypoglycemia unawareness” (reduced warning symptoms)
People using insulin or sulfonylureas (such as glipizide or glyburide)
Those aiming for very tight A1C targets

Hypoglycemia unawareness deserves special attention. After repeated low episodes, the body may stop producing early warning signs like shakiness or sweating. That increases the chance that a mild low becomes a severe one without warning.

What the 2026 ADA Standards Emphasize

The 2026 Standards do not represent a sudden shift, but they continue an evolution toward safer diabetes care. Key themes include:

1. Broader Offering of Continuous Glucose Monitoring (CGM)

CGMs are wearable sensors that track glucose levels throughout the day and night. The ADA recommends offering CGM to people with diabetes who use insulin and to others who may benefit, rather than restricting access to only the highest-risk patients.

CGMs can:

Alert users before glucose drops dangerously low
Show overnight patterns
Help identify repeated low trends

They do not eliminate hypoglycemia risk, but evidence shows they can reduce time spent in low ranges when used consistently and correctly.

2. Screening for Hypoglycemia Unawareness

The guidelines emphasize routine assessment of whether patients are recognizing early low symptoms. If awareness is reduced, clinicians may temporarily relax glucose targets to allow the body’s warning system to recover.

3. Medication Choices That Lower Risk

When appropriate, clinicians are encouraged to select medications with lower hypoglycemia risk, especially for older adults or those with prior severe episodes. Some newer diabetes medications rarely cause low blood sugar when used alone, while insulin and sulfonylureas carry higher risk.

This does not mean everyone should stop older medications. Instead, it supports regular medication review, particularly after hospitalizations or severe events.

4. Routine Education and Written Action Plans

The ADA continues to stress that every patient at risk should know:

Early symptoms of low blood sugar
The “15-gram rule” for mild lows (take 15 grams of fast-acting carbohydrate, recheck in 15 minutes)
When to call 911
How and when to use glucagon

Modern Glucagon: Easier to Use in Emergencies

Glucagon is a hormone that raises blood sugar quickly and is used for severe hypoglycemia. In recent years, the FDA has approved ready-to-use nasal and autoinjector glucagon products. These options do not require mixing powder and liquid, which was a barrier in older kits.

The ADA recommends that people at risk of severe hypoglycemia have glucagon available and that family members, coworkers, or school staff know how to use it.

Important safety reminder: Never give food or drink to someone who is unconscious or unable to swallow. Call 911 and administer glucagon if available.

What Medicare Coverage Means for Older Adults

One of the most meaningful access changes in recent years has come from the Centers for Medicare & Medicaid Services (CMS). Medicare expanded coverage criteria for continuous glucose monitors, allowing more beneficiaries who use insulin — and some with documented hypoglycemia — to qualify.

Coverage still depends on meeting specific requirements and documentation. Prior authorization, cost-sharing, and supplier availability can affect access. Not every device is covered for every patient.

For older adults — who are at particularly high risk of falls and injury from severe lows — broader CGM coverage may make prevention more realistic.

Recognizing and Treating Mild Lows

Early symptoms can include:

Shakiness
Sweating
Rapid heartbeat
Confusion
Irritability

For mild hypoglycemia (typically below 70 mg/dL):

Take 15 grams of fast-acting carbohydrate (glucose tablets, juice, regular soda).
Wait 15 minutes.
Recheck glucose and repeat if still low.

If someone becomes unconscious, has a seizure, or cannot safely swallow, call emergency services immediately.

Access and Equity Gaps Remain

Despite advances, access to hypoglycemia prevention tools is not equal.

CGMs can be expensive for people without strong insurance coverage.
Medicaid coverage varies by state.
Digital literacy and smartphone access affect device use.
Rural communities may have limited diabetes education programs.

Language barriers and limited health literacy can also make training on devices or glucagon harder to access. These gaps mean that severe hypoglycemia prevention is not only a medical issue, but also a public health and policy challenge.

What This Means for Readers

Severe hypoglycemia is often preventable. Updated national guidance emphasizes earlier use of glucose monitoring technology, safer medication selection when appropriate, and ensuring that families are trained for emergencies.

If you or a loved one has diabetes:

Ask your clinician whether CGM is appropriate and covered by your insurance.
Review medications to assess hypoglycemia risk.
Make sure someone close to you knows how to use glucagon.
Have a written low-blood-sugar action plan.

Modern tools can reduce risk, but they do not remove it entirely. Staying informed, reviewing medications regularly, and planning ahead remain the strongest protections.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.